Skip to content

A Pilot Study of Acute Coronary Syndrome Registry Project in Iwate Prefecture

A Pilot Study of Acute Coronary Syndrome Registry Project in Iwate Prefecture - A Pilot Study of ACS Registry Project in Iwate

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000046643
Enrollment
2453
Registered
2022-04-01
Start date
2014-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction

Interventions

None listed

Sponsors

Division of Cardiology, Department of Internal Medicine, Iwate Medical University
Lead Sponsor
1) Iwate prefectural Chubu hospital 2) Iwate prefectural Iwai hospital 3) DIwate prefectural Isawa hospital 4) Iwate prefectural Ofunato hospital 5) Iwate prefectural Miyako hospital 6) Iwate prefectural Ninohe hospital 7) Japanese Red Cross Morioka Hospital 8) Iwate prefectural Kuji hospital 9) Iwate prefectural Kamaishi hospital 10) Iwate prefectural Chuo hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who were hospitalized to major 11 hospitals in Iwate prefecture for acute myocardial infarction met the third universal definition (the details are listed below) between October 1, 2014 and December 31, 2018. (1) Within 4 weeks of onset and meet under these conditions any one of the following criteria meets the diagnosis for MI: (2) Detection of a rise and/or fall of cardiac biomarker values [preferably cardiac troponin (cTn)] with at least one value above the 99th percentile upper reference limit (URL) and with at least one of the following: i) Symptoms of ischemia. ii) New or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB). iii) Development of pathological Q waves in the ECG. iv) Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. v) Identification of an intracoronary thrombus by angiography or autopsy. vi) Cardiac death with symptoms suggestive of myocardial ischemia and presumed new ischemic ECG changes or new LBBB, but death occurred before cardiac biomarkers were obtained, or before cardiac biomarker values would be increased.

Exclusion criteria

Exclusion criteria: 1) The patients were excluded who were admitted to the hospital with a diagnosis of acute myocardial infarction, but the final diagnosis on discharge were unstable angina pectoris, myocarditis or takotsubo cardiomyopathy. 2) Percutaneous coronary intervention or coronary artery bypass grafting related MI.

Design outcomes

Primary

MeasureTime frame
In-hospital mortality

Secondary

MeasureTime frame
(1) The treatments of acute myocardial infarction (door to balloon time in percutaneous coronary intervention, device used, final TIMI flow grade, coronary artery bypass grafting, presence of assisted circulation device, presence of ventilator). (2) Hospitalization days and outcome at discharge (survival to discharge, death, transfer).

Countries

Japan

Contacts

Public ContactYumiko Okuyama

Iwate Medical University Division of Cardiology, Department of Internal Medicine

yrkoeda@iwate-med.ac.jp+81-19-613-7111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026